Jennifer Champagne, PharmD, RPh, BCPS

Researchers examined the effects of the COVID-19 pandemic on individuals with nonalcoholic fatty liver disease and alcohol-associated liver disease.

In a prospective study, researchers observed the effect of gastrointestinal symptoms on COVID-19 outcome.

Investigators assessed virological, biochemical, and clinical outcomes following cessation of nucleos(t)ide analog therapy in patients with chronic hepatitis B.

Investigators assessed the association between cost sharing and likelihood of uncomplicated presentation and surgical management of acute appendicitis or diverticulitis.

Investigators assessed the safety and efficacy of treatment with spore-forming probiotics in reducing symptoms of functional dyspepsia.

Investigators reviewed the connection between communication skills and patient satisfaction and offered recommendations for improving the patient-provider relationship.